Shukla Sath
CIK 0001782817
Chief Financial OfficerDirector
Filings
8
Latest Feb 5, 2025
Issuers covered
1
Showing
8 of 8
Page 1
Track record
11 of 11 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 73% | +3.7% | +7.2% | +16.9% | -19.4% |
| 90 days | 11 | 82% | +11.1% | +7.1% | +32.7% | -15.3% |
| 180 days | 11 | 55% | -32.6% | +3.1% | +41.7% | -157.7% |
| 365 days | 11 | 27% | -50.7% | -43.5% | +47.7% | -162.3% |
Issuers
Companies where Shukla Sath has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 8 | Feb 5, 2025 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|